Anti-counterfeit Pharmaceutical Packaging Market Segmentation:
Technology Segment Analysis
The radio frequency identification is rising as the most dominant technology and is projected to garner 34.5% of the market share by 2035. The market growth can be attributed to the rising requirement for the real-time monitoring of the drugs. RFID tags are different from conventional tags and can be read wirelessly across various units. These features make RFID tags highly efficient. Also, the segment is gaining traction owing to its ability to seamlessly serialize. Governments across the world are investing to accelerate the deployment of RFID systems. Additionally, technological advancements have remarkably reduced the cost of these tags, making them commercially viable to use.
Application Segment Analysis
The serialization segment is anticipated to witness significant growth and is expected to garner a significant market share by 2035. The push for serialization has been propelled by the stringent regulatory mandates. In various European Nations, laws require prescription medicines to carry unique tamper-evident features. These types of mandates have compelled pharmaceutical companies to include serialization systems, further bolstering the expansion of the market. Additionally, serialization renders significant security benefits by inculcating end-to-end traceability methods. These technological advancements transform serialization into a strategic advantage, making it a prominent growth driver.
Our in-depth analysis of the Anti-counterfeit pharmaceutical packaging market includes the following segments:
|
Segment |
Sub Segments |
|
Technology |
|
|
Application |
|
